A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B
Background: International guidelines for hepatitis B infection (HBV) recommend initiating antiviral treatment based on viral replication with inflammation or fibrosis. HBV viral loads and liver fibrosis measurements are not widely available in resource-limited countries. Aim: To develop a novel scor...
Saved in:
Main Author: | Geeratragool T. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/81933 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
by: Y. Wang, et al.
Published: (2018) -
Baseline and on-treatment predictors of chronic hepatitis B patients receiving pegylated interferon therapy in Asia
by: Phunchai Charatcharoenwitthaya, et al.
Published: (2018) -
Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B
by: Umaporn Limothai, et al.
Published: (2022) -
Observation of genotype C infected chronic hepatitis B patients in clinical practice
by: Myo Nyein Aung, et al.
Published: (2018) -
Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B
by: Huang, Daniel Q., et al.
Published: (2023)